The system reported Oct. 27 that the $28 million acquisition of the hospital from West Reading, Pa.-based Tower Health has resulted in an approximate $7.4 million loss on its investment in the first six months of operations.
Temple University’s 60% stake in the hospital was originally valued at $16.8 million, but the value of that investment was $9.4 million as of June 30, according to the filing. Temple University also had approximately $23.9 million in receivables due from the nonprofit now running the hospital.
Redeemer Health and the Philadelphia College of Osteopathic Medicine each own a 20% stake in the hospital.
The investment loss on the hospital was included in audited financials, which showed Temple University reporting an operating loss of $58.8 million for the year ending June 30.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
